Education
About Us
Working with TipRanks
Follow Us
Iconovo AB (SE:ICO)
:ICO
ICO Stock Chart & Stats
kr1.14
-kr0.10(-3.02%)
At close: 4:00 PM EST
kr1.14
-kr0.10(-3.02%)
Day’s Range― - ―
52-Week Rangekr0.95 - kr4.69
Previous CloseN/A
Volume7.53K
Average Volume (3M)46.24K
Market Cap
kr60.22M
Enterprise Valuekr21.06M
Total Cash (Recent Filing)kr18.55M
Total Debt (Recent Filing)kr5.32M
Price to Earnings (P/E)―
Beta-0.37
Next Earnings
Feb 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.17
Shares Outstanding53,061,250
10 Day Avg. Volume58,575
30 Day Avg. Volume46,237
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)0.51
Price to Sales (P/S)22.59
P/FCF Ratio-1.43
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ICO FAQ
What was Iconovo AB’s price range in the past 12 months?
Iconovo AB lowest stock price was kr0.95 and its highest was kr4.69 in the past 12 months.
What is Iconovo AB’s market cap?
Iconovo AB’s market cap is kr60.22M.
When is Iconovo AB’s upcoming earnings report date?
Iconovo AB’s upcoming earnings report date is Feb 27, 2026 which is in 64 days.
How were Iconovo AB’s earnings last quarter?
Iconovo AB released its earnings results on Oct 24, 2025. The company reported -kr0.167 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.167.
Is Iconovo AB overvalued?
According to Wall Street analysts Iconovo AB’s price is currently Overvalued.
Does Iconovo AB pay dividends?
Iconovo AB does not currently pay dividends.
What is Iconovo AB’s EPS estimate?
Iconovo AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Iconovo AB have?
Iconovo AB has 53,061,250 shares outstanding.
What happened to Iconovo AB’s price movement after its last earnings report?
Iconovo AB reported an EPS of -kr0.167 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.483%.
Which hedge fund is a major shareholder of Iconovo AB?
Currently, no hedge funds are holding shares in SE:ICO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Iconovo AB
Iconovo AB (publ) develops and licenses inhalation devices in Sweden. It develops ICOres, a flexible multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler, as well as provides customized inhalation solutions. It serves generic companies. The company has an agreement with Immune System Regulation AB for the development of an inhaled covid-19 vaccine in Iconovo's inhaler ICOone; and Respiratorius AB (publ) to develop inhalation product to treat COPD. Iconovo AB (publ) was founded in 2013 and is based in Lund, Sweden.
Technical Analysis
SciBase Holding AB
―
Clinical Laserthermia Systems AB Class B
―
Scandinavian Real Heart AB
―
ScandiDos AB
―
Arcoma AB
―